Skip to main content

Day: February 10, 2026

Spectral AI Names Vincent S. Capone as Chief Executive Officer

DALLAS, Feb. 10, 2026 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that the Company’s Board of Directors has appointed Vincent S. Capone as Chief Executive Officer of the Company, effective February 9, 2026. The appointment of Mr. Capone, who currently serves as the Company’s Chief Financial Officer and General Counsel, comes as Spectral AI transitions towards commercialization of its proprietary, non-invasive, AI-driven burn wound assessment device – the DeepView® System. “Vince brings a unique set of leadership skills to his new role, combining a background in law, accounting, finance and operations management supported by a strong vision...

Continue reading

Jayud Global Logistics Signs 3-Year Partnership with DBG Technology Subsidiary Guangdong Electronics

SHENZHEN, China, Feb. 10, 2026 (GLOBE NEWSWIRE) —  Jayud Global Logistics Limited (NASDAQ: JYD) (“Jayud” or the “Company”), a leading end-to-end supply chain solutions provider based in Shenzhen specializing in cross-border logistics, today announced that it has signed a three-year cooperation agreement (the “Agreement”) with Guanghong Electronics, a wholly-owned subsidiary of DBG Technology Co., Ltd. (300735.SZ). The Agreement focuses on providing comprehensive logistics and transportation services, including land and air freight from China to Hong Kong, as well as customs-related processes. This collaboration leverages Jayud’s extensive logistics network and expertise in cross-border trade to support DBG Technology’s expanding global operations. DBG, a prominent Electronic Manufacturing Services...

Continue reading

Nasdaq Launches new Private Capital Indexes, expanding Its Private Capital Solutions Platform

By enhancing Nasdaq Private Capital Solutions, the platform reinforces its capacity to deliver high‑quality benchmarking, robust data, and advanced analytics for today’s increasingly complex private markets. The new benchmark suite extends this capability with broader market representation and workflow‑ready insights across private capital strategies. NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced the launch of the Nasdaq Private Capital™ Indexes, a new suite of benchmarks designed to deliver transparency, representativeness, and robustness to private markets. Built to help institutional investors and consultants benchmark performance, analyze exposures, and navigate private capital markets with precision, the indexes introduce rules‑based rigor and consistent measurement to segments that...

Continue reading

ZenaTech’s Drone as a Service Expands Builder Services Capability Delivering Drone-Driven Speed and Precision to Surveying for Homebuilders

VANCOUVER, British Columbia, Feb. 10, 2026 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces its integration of drone-based workflows into land surveying services for national homebuilders, providing improved speed, precision and reliability to facilitate permits. The company plans to expand its builder services through DaaS operations enablement via the specialized skills of one of its recently acquired land surveying firms, Cardinal Civil Resources, which offers a strong history of serving major U.S. homebuilders to expand the company’s access into the homebuilding sector. National home builders that buy finished...

Continue reading

Solar Drone, a Wholly Owned Subsidiary of VisionWave Holdings, Inc., Reports Executive Meetings in Italy and Ongoing Business Development Discussions in Select Middle Eastern Markets

TEL AVIV, Israel, Feb. 10, 2026 (GLOBE NEWSWIRE) — Solar Drone, a wholly owned subsidiary of VisionWave Holdings, Inc. (NASDAQ: VWAV) and a provider of drone-based cleaning and maintenance solutions for solar power plants and high-voltage infrastructure, announced today that it is continuing business development discussions regarding possible opportunities in Middle Eastern markets, including Egypt and the United Arab Emirates, following a series of executive meetings held last week in Naples, Italy. The meetings were led by Solar Drone’s CEO, CTO, and COO, who met with leading prospective customers and partners from Egypt and the Emirates. These discussions followed successful live demonstrations in Italy, where Solar Drone’s drone-based cleaning operations are already deployed in active commercial environments. During the demonstrations,...

Continue reading

NANO Nuclear to Hold First Quarter Business Update on February 17, 2026

New York, N.Y., Feb. 10, 2026 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor and technology company focused on developing clean energy solutions, today announced it will host its first quarter fiscal 2026 business update webcast on Tuesday, February 17, 2026, at 5:00 p.m. ET. The webcast will follow the anticipated filing of the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2025. Additional details will be available in the Investor Relations section of NANO Nuclear’s website at https://ir.nanonuclearenergy.com/.Event:   NANO Nuclear Energy Inc. Q1 FY 2026 Business Update WebcastDate:   Tuesday, February 17, 2026Time:   5:00 p.m. ETLive Call:   1-877-269-7756 (U.S. Toll Free) or 1-201-689-7817 (International)Webcast:   https://ir.nanonuclearenergy.com/news-events/events     A...

Continue reading

Zhengye Biotechnology Holding Limited Issues 2026 Chairman’s Letter to Shareholders

Jilin, China, Feb. 10, 2026 (GLOBE NEWSWIRE) — Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccines in China, today announced that Mr. Zhenfa Han, Chairman of the Board of Directors of Zhengye, has issued a letter to shareholders. In the letter, Mr. Han highlights the Company’s research and operational milestones achieved in 2025 and outlines Zhengye’s strategic priorities for growth in 2026. The full text of the letter follows. Dear Shareholders, As we enter 2026, on behalf of the management of Zhengye Biotechnology Holding Limited, I am proud of the milestones we achieved in 2025 and would like to share our strategic vision for 2026 and the...

Continue reading

Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™

Kennewick, WA, Feb. 10, 2026 (GLOBE NEWSWIRE) — Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy™ (PRnT™) with its innovative RadioGel® technology, today provided an update on its ongoing efforts to secure FDA Investigational Device Exemption (IDE) approval for human clinical trials of RadioGel® in advanced human therapy applications. RadioGel® is a targeted radiation therapy designed to deliver precise, localized beta radiation to solid tumors via direct injection, minimizing exposure to surrounding healthy tissue and reducing systemic migration of the radiopharmaceutical agent. Over the past several years, the Company has engaged extensively with the FDA, successfully addressing feedback from more than 40 individual reviewers—many comments stemming from frequent review...

Continue reading

Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses

FLORHAM PARK, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company, today announced receipt of $12.2 Million in net cash proceeds from the sale of approximately $126.3 Million of its unused New Jersey net operating losses (NOLs) and $1.9 Million of unused New Jersey research and development (R&D) tax credits. The NOLs and R&D tax credits sale was administered through New Jersey’s Technology Business Tax Certificate Transfer Program, which enables qualified New Jersey-based technology and life science companies to sell their New Jersey NOLs and R&D tax credits for cash to buyers who purchase and apply the credits to reduce taxable income. The program is operated by the New Jersey Economic Development Authority (NJEDA),...

Continue reading

Australian Maritime College and HII Report Near-Perfect Availability as REMUS 100 Completes 935 Missions with Only Two Days of Downtime

NEWNHAM TAS, Australia, Feb. 10, 2026 (GLOBE NEWSWIRE) — The Australian Maritime College (AMC) and HII (NYSE: HII) today announced a major reliability milestone for AMC’s Legacy REMUS 100 autonomous underwater vehicle (AUV). Over seven years, the AMC REMUS 100 completed 935 operational deployments with only two days of downtime caused by material issues. During this period the AUV supported the training of more than 400 Royal Australian Navy AUV operators. Despite frequent use in challenging environments, the system maintained operational availability above 99.9%, which is a standout result for autonomous maritime technology. This performance record reinforces the REMUS 100’s reputation as one of the most dependable autonomous underwater systems operating today. In 2026, HII REMUS will celebrate 25 years of reliable, innovative...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.